Burak Oğulcan Yıldırım

Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in the management of type 2 diabetes owing to their effectiveness in glycemic control and weight reduction. Given the increasing use of GLP-1RAs, further research is warranted to better understand their cardiac...